BCIQ Profiles

Company Profile Report

April 29 Quick Takes: After ADC approval, Immunomedics raises $420M for rollout; plus Genespire, Vertex, Ocumension and Cadent

Immunomedics raises $420M to roll out Trodelvy for breast cancer
Immunomedics Inc. (NASDAQ:IMMU) raised $420 million late Tuesday through the sale of 14.7 million shares at $28.50 in a bumped-up follow-on. The price is

Read the full 335 word article

How to gain access

Continue reading with a
two-week free trial.